Company Data

Cadrenal Therapeutics Inc.

Fundamental Analysis:
โ€Œ
Cadrenal Therapeutics Inc.
โ€Œ
Cadrenal Therapeutics Inc.
Fundamental Analysis:
Ticker
CVKD
Current Price
$0.4449 0.47%
Market Cap
$7.1M
Price Target
Refer to Report
Volume
10.1K
52wk Range
$0.36 - $3.14
Advanced Market Data

Overview

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Inbox Intel from Channelchek.

Informed investors make more money. And itโ€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy